POLYNUCLEOTIDE REGULATION OF THE IMMUNE SYSTEM. II[
p o l y A : U in e n h a n c i n g a n t i b o d y s y n t h e s i s is to e x p a n d a small p o p u l a t i o n of t h y m i c -i n f l u e n c e d cells. N o effect on b o n e m a r r o w cells was a p p a r e n t .
Materials and Methods
Animals.--BALB/Aj mice originally derived from those of Dr. William Murphy, Department of Microbiology, The University of Michigan (11) , were inbred in our laboratory. C57BL/6j mice were obtained from Jackson Laboratories, Bar Harbor, Maine. The mice were fed Purina mouse chow and water ad libitum. New Zealand white rabbits approximately 1-2 kg were obtained from a local supplier.
Antlgen.--SRBC were obtained from the Colorado Serum Company, Denver, Colo. The cells were stored at 4°C in modified Alsever's solution, washed three times, and resuspended in 
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FIG. 1.
Restoration of immune response of neonatally thymectomized mice by thymic ]ymphocytes. Mice received 4 X l0 s SRBC 4-th)nnic lymphocytes intravenously and spleens were removed 6 days later and assayed for RFC. Each point represents the arithmetic mean of three separate experiments with four to five mice per group in each experiment.
phosphate-buffered saline (PBS), pH 7.2, for injection. In all instances mice received 4 X 10 s SRBC intravenously.
ttomoribopolynucleotides.--Polyadeny|ic acid (poly A) potassium salt (lots 110748, 11-57-301) and polyuridylic acid (poly U) ammonium salt (lots 411754, 11-6-308) were purchased from Miles Laboratories, Elkhart, Ind. Each polymer was stored at -20°C at a concentration of 15 mg/ml in PBS, pH 7.2. Polymers were complexed in vitro to form poly A:U by mixing equal amounts of the polynucleotides before use .
Heterologous Anti-Thymocyte Serum.--Anti-mouse thymocyte serum (ATS) was prepared by the method of Gray eta|. (12) . Single cell suspensions of thymic lymphocytes from 5-wk old female BALB/Aj mice were washed three times and resuspended in PBS, pH 7.2. The washed suspension was mixed with an equal volume of Freund's complete adjuvant (Difco Laboratories, Detroit, Mich.) and injected into the footpads of NZW rabbits such that each rabbit received 1 X 10 s thymic lymphocytes. 4 wk later the rabbits received intravenous injections of thymic lymphocytes in PBS for 3 consecutive days for a total of 3 X l0 s cells. The rabbits were bled 7 and 10 days after the late injection. Each serum was absorbed with SRBC and BALB/Aj mouse RBC and stored at --20°C. The antiserum was found to agghiti-nate thymic lymphocytes to a dilution of 1:512. 0.4 ml or more antiserum injected intraperitoneally 2-3 days before an intravenous injection of SRBC resulted in maximum (90?95%) suppression of the immune response to SRBC as measured by the rosette technique. In all cases the serum was inactivated by heating at 56°C for 30 min before use.
Cell Preparations.--Single cell suspensions of thymic lymphocytes used to prepare ATS or to restore thymectomized or irradiated mice were obtained by mincing the thymic lobes of 4-5-wk old BALB/Aj mice in cold PBS, 7.2. The cell suspension was passed through a No. 80 gauge stainless steel mesh into PBS, washed three times, and resuspended in PBS, pH 7.2, to appropriate concentrations. Suspensions of bone marrow cells were prepared from 9-10-wk old Balb/Aj mice. The marrow was flushed from femurs and tibias by means of a syringe and a 26 gauge needle containing cold Eagle's basal medium. ,The extruded plugs were dispersed by aspiration with a 21 gauge needle and the cells were washed three times in cold PBS, 7.2, and resuspended to an appropriate volume.
Thymectomy.--18-24-hr old mice were thymectomized according to the method of Sjodin et al. (13) . Mice were anesthetized with ether and a longitudina ! incision was made into the mediastinal cavity to the level of the fourth rib. The thymic lobes were removed by aspiration and the wound was closed with a single silk suture. Before removal of spleens for rosette analysis, the mice were examined with the aid of a dissecting microscope for the presence of thymic remnants. Mice with thymic remnants were excluded from the study.
Transplantation.--BALB/Aj mice were the recipients of skin from 5-6-wk old female C57BL/6j mice. Recipient mice were anesthetized with pentobarbital anesthesia and the skin was removed from their backs in whole thickness in the shape of a rectangle approximately 2 ;K 2 cm. A skin fragment of a slightly larger size was removed from the abdomen of the donor and sutured in place using 5-0 surgical thread. The mice were housed separately and observed each day for signs of rejection.
Irradiation.--BALB/Aj mice, 9-10-wk old were exposed to 800 R whole-body irradiation at a distance of 100 cm from a ~°Co source delivering 67 R/min.
Rosette Assa~.--6 days after injection of SRBC, the immune response to SRBC was measured by the rosette assay (14, 15) . Spleens from each experimental group were pooled, dispersed, and washed in PBS, pH 7.2. To 1 ml of the washed, monodisperse spleen cell suspension was added 0.1 m] of a 10% suspension of washed SRBC; this mixture was incubated for 1.5 hr at 37°C and overnight at 4°C. SRBC adhere to cells producing anti-SRBC antibody to form a "rosette." Rosette-forming cells (RFC) were enumerated by counting the spleen cell-SRBC mixture in a hemocytometer at 200 X magnification. Approximately 5,000-10,000 spleen cells were counted, depending on individual experiments.
RESULTS

Restoration of the Immune Response to SRBC in NTx Mice by Thymic Lymphocytes or Poly A :
U.--The ability of thymic lymphocytes to restore in our system an immune response impaired by neonatal thymectomy is shown in Fig. 1 . It may be seen that NTx reduced by 90 % the numbers of RFC occurring in response to SRBC, while l0 s thymic lymphocytes restored the response of NTx mice back to 54% of normalcy.
In testing whether poly A:U exerted its adjuvant action on the thymic lymphocyte in this system, the effect of poly A:U alone, without lymphocytes in NTx mice, also was determined. Surprisingly, NTx mice injected intravenously with SRBC plus poly A:U at a concentration of 1200 ~g (600 ~g of each polymer) were restored on day 6 to full immunocompetence with respect to R F C , in the absence of injected thymic lymphocytes (Fig. 2) . As the quantity of poly A: U was lessened, the number of R F C produced decreased as a straightline function. BALB/Aj recipients received whole-thickness skin grafts from C57BL/6j donors. Mice receiving poly A: U were injected with 600 #g intraperitoneally 12, 24, and 72 hr after grafting. * () indicates 95% confidence interval.
Since neonatal thymectomy depresses cellular immunity as well as circulating antibody to SRBC, the experimental procedure was extended to determine whether NTx mice treated with poly A : U alone would regain the capacity to reject skin homografts. Accordingly, N T x and unoperated B A L B / A j mice were grafted with skin from C57BL/6j donors. Groups of N T x and unoperated recipients received 600 ~g of poly A : U intraperitoneally 12, 24, and 72 hr after grafting. As can be seen in Table I , skin grafted on mice with an intact thymus had a mean survival time of 13.5 days, while the mean survival time of grafts on NTx mice was extended to 24 days. However, NTx mice which received poly A:U were able to reject grafts at the same rate as unoperated mice. Thus, cellular as well as humoral immunity appeared to be restored by poly A:U in NTx mice, corroborating earlier studies on the effect of poly A:U on cellmediated immune reactions (16) . by Poly A : U. To confirm the competence of poly A: U in overcoming inhibiting effects on lymphocytes, a different approach was utilized where injection of ATS was substituted for neonatal thymectomy. Accordingly, varying doses of poly A:U along with SRBC were injected into normal mice 3 days after they received intraperitoneally 0.4 ml of ATS. Splenic RFC were assayed 6 days after the injection of antigen. As can be seen in Fig. 3 , untreated mice produced 42,000 RFC/10 ~ spleen cells while mice pretreated with ATS produced only 5 % of this number. 1200 /~g of poly A:U increased the response of ATS-treated mice 10-fold. As was the case with poly A:U administered to NTx mice, when the quantity of poly A:U was lessened, the number of RFC produced decreased.
Restoration of Immune Response to SRBC in Normal Mice Treated with A TS
From the preceding data it was evident that poly A:U injection could readily replace the need for thymic lymphocytes in animals depleted of such cells. It was not apparent, however, whether the restorative effects of poly A:U con-stituted an actual replacement of a polynucleotide-like hormone from thymic lymphocytes or whether its effects were dependent on the amplification of a small number of residual thymic cells which might have seeded or influenced the peripheral lymphoid tissue before thymectomy.
In testing this question, it was reasoned that if both thymectomy and ATS treatment were combined, the number of any residual cells bearing thymic influence would be decreased further than with either treatment alone. If poly A:U action was based on amplifying these cells, its effect should have been reduced if the number of cells to be amplified were reduced. If poly A: U were simply replacing the need for hormone action on a nonthymic cell, then decreasing the residual cells remaining after thymectomy should have no effect on poly A: U enhancement. The results agreed with the amplification hypothesis Mice received 4 N 108 SRBC ± 600 #g poly A:U intravenously 3 days after intraperitoneal injection of 0.4 ml ATS. Values represent arithmetic mean of three separate experiments with four to five mice per group in each experiment.
N. D. = not done.
and are as follows: NTx mice received ATS intraperitoneally 3 days before an intravenous injection of SRBC or SRBC and poly A:U. As may be seen in Table II , unoperated mice produced 23,000 RFC/106 spleen cells. Thymectomy or ATS treatment reduced the immune response by 90% to 1600-2000 RFC/10 a spleen cells. Combination of thymectomy and ATS treatment reduced further the RFC response to 615 RFC/106 spleen cells. When NTx or ATS-treated mice received 600 /zg of poly A:U the expected degree of restoration was achieved. However, although poly A:U was able to elevate the immune response 4-fold in mice receiving both thymectomy and ATS treatment, the total number of RFC ultimately produced was diminished, parallelling the reduction in the number of thymic antigen-reactive cells achieved by combination of thymectomy and ATS treatment. The results presented in Table II suggested that the ability of poly A:U to restore immunocompetence to NTx mice was dependent on the expansion of a small number of ARC which might be present in the peripheral lymphoid tissue before thymectomy. Since lethally irradiated mice require both thymic-derived and bone marrow-derived cells to produce an immune response to SRBC (1), this model system was employed to distinguish any possible effects of poly A:U on thymic ARC and/or AFPC of bone marrow origin. Thus, unoperated mice which received 800 R whole-body irradiation 24 hr previously were injected with either 4 X 10 s SRBC, SRBC and thymic lymphocytes, SRBC and bone marrow cells, or SRBC and a combination of the two cell types. Spleens were assayed for RFC 9 days after the injection of antigen.
No increase in RFC was found in the spleens of irradiated mice which re- ceived SRBC only or SRBC plus bone marrow cells, as expected. Mice which received SRBC and a combination of thymic lymphocytes and bone marrow cells had 1.8 N 105 RFC/spleen which was 63 times as many RFC as mice receiving SRBC and thymic cells only, (2.9 X 10 ~ RFC). Thus, the need for both bone marrow cells and thymic-influenced lymphocytes in the restoration of immunocompetency under these conditions was demonstrated.
With this established, the possibility that poly A:U could amplify the function of small numbers of ARC was studied by injecting lethally irradiated mice with poly A:U and graded numbers of thymic lymphocytes plus a constant number in excess of bone marrow cells and antigen. Using minimal replacement levels of thymus cells (4 X 104-5 N 106), a pronounced effect of poly A:U on thymic cells was seen, as is shown in Fig. 4 . Thus, the addition of poly A:U to just 40,000 thymic lymphocytes enabled the expression of an immune response in irradiated mice receiving bone marrow cells and SRBC. This low number of thymocytes without poly A:U was nonfunctional. The immunoenhancing effect of poly A:U decreased as the number of thymic lymphocytes injected was increased, suggesting that with higher numbers of thymus cells, the number of bone marrow cells became a limiting factor in the expression of an immune 10 6 rY" response. Thus, when ARC were present in excess of AFPC, the maximum number of thymus-marrow cell interactions probably occurred, and further increases in the number of ARC would not elevate the number of RFC produced.
To test for any effect of poly A: U on bone marrow cells, irradiated mice were injected in like experiments with graded numbers of bone marrow cells, SRBC, poly A:U, and a constant number, 108, of thymic lymphocytes. Spleens were removed on day 9 and assayed for RFC. As can be seen in Fig. 5 , the hum-ber of RFC per spleen increased from 5 X 10 3 to 1.2 X 10 5 as the number of bone marrow cells injected was increased from 2 X 10 6 to 4 X 10 7. However, when poly A:U was injected with 2 X 10 6 or 10 7 bone marrow cells, no adjuvant effect was observed. Only when the number of bone marrow cells was increased to 4 X 10 7, such that the thymocytes became limiting, did a rise in RFC become apparent with poly A:U treatment. This probably reflected action on the thymocyte and not the bone marrow cell.
DISCUSSION
The ability of poly A:U to restore the RFC response in NTx-or ATS-treated mice supports the hypothesis that this adjuvant exerts its action on the thymicinfluenced ARC, in addition to the effect on the macrophage recorded in the preceding manuscript (10) . That thymectomy or ATS treatment reduced the number of thymic-influenced ARC necessary for the full expression of immunocompetence is documented by the ability of thymic lymphocytes to restore RFC as well as the PFC response of NTx-or ATS-treated mice (2, 17, 18) . As RFC have been shown to be actively synthesizing antibody (19, 20) and antibody-forming cells are of bone marrow rather than thymic origin (3) (4) (5) , it is unlikely that thymic lymphocytes were functioning as RFC precursors, but rather as ARC. That thymic lymphocytes in this system do not end up as RFC is also suggested by the fact that irradiated mice which received a combination of thymic lymphocytes and bone marrow cells produced 63-fold more RFC than irradiated mice receiving thymic lymphocytes and SRBC only. The observation (8) that poly A:U shortened the time required for the attainment of the peak number of PFC responding to SRBC might suggest that the polynucleotides stimulated the proliferation of AFPC after such cells interacted with ARC. This is probably not the case inasmuch as poly A:U injected 1 day after antigen in normal mice did not exert any adjuvant effect3
Experiments by Shearer and Cudkowicz indicate that one of the first steps in the initiation of the immune response to SRBC is an antigen-dependent proliferation Of thymic-derived ARC (7). Accordingly, poly A:U might influence the rate of activation and/or proliferation of ARC, thus amplifying the small number of ARC which were present in the peripheral lymphoid tissue before, and persisting after thymectomy, as attested by the further reduction in RFC in NTx mice by ATS treatment. Such a possibility is supported by the observation that poly A:U allowed the detection of an immune response in irradiated mice receiving bone marrow cells, SRBC, and as few as 40,000 thymic lymphocytes. The decreased adjuvant action of poly A:U as the bone marrow cell population became limitingl further emphasizes that thymic lymphocytes, rather than the bone marrow cells, are stimulated by the homoribopolymers. In addition, experiments in progress in which thymic lymphocytes were incubated with poly A:U in vitro before injection into thymectomized mice indicate that poly A:U exerts its stimulatory effect directly on thymic lymphocyte membranes when increasing immunocompetence in NTx mice.
The restoration of immunocompetence in NTx mice by the implantation of thymus organs in diffusion chambers (21, 22) or the injection of cell-free extracts of thymic tissue (23, 24) has led to the suggestion that the thymus may secrete a competence-inducing humoral factor. This raises the question whether the polynucleotides act like a thymic hormone. However, the lessening of the adjuvant action of poly A:U as the number of residual thymocytes in NTx mice was decreased further by ATS treatment, as well as the inability of poly (A:U) to restore RFC in irradiated mice reconstituted with bone marrow cells only, argue against this possibility. It is important, however, that in experiments involving the use of thymic extracts and NTx animals attention be given to the fact that small numbers of residual thymic cells remain which might be stimulated to a remarkable degree by nucleic acids released on extraction of the thymus, acting like poly A:U to restore competency.
SUIVIMARY
Polyadenylic-polyuridylic acid complexes, a potent adjuvant to the immune response, were tested for action on thymic-influenced and bone marrowderived lymphocytes in model systems deficient in one or the other of these cells.
Adult mice, thymectomized at birth or mice treated with heterologous antithymocyte serum produced 90--95 % fewer splenic rosette-forming cells than normal mice in response to an injection of sheep erythrocytes. Intravenous injection of complexes of homoribopolynucleotides, polyadenylic and polyuridylic acids, poly A:U with SRBC restored immunologic competence to NTx-or ATS-treated mice such that they produced normal or near normal levels of splenic RFC. In addition, injection of poly A:U enabled NTx mice to reject allogeneic skin grafts at the same rate as control mice with an intact thymus. Further reduction in residual thymocytes by combining neonatal thymectomy with ATS treatment reduced the number of anti-SRBC RFC induced by poly A:U.
Lethally irradiated mice which received SRBC, excess bone marrow cells, and as few as 40,000 thymic lymphocytes were stimulated by poly A:U to produce RFC. No adjuvant effect was observed when irradiated mice received excess thymic lymphocytes and low doses of bone marrow cells with poly A:U.
The results suggested that the adjuvant action of poly A:U was exerted on the thymic-influenced, antigen-reactive cell and that restoration of immunocompetence to NTx-or ATS-treated mice was caused by amplification of a small number of residual antigen-reactive cells which were influenced by the thymus in utero before thymectomy, or which survived treatment with ATS.
